These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4542594)

  • 21. Letter: Variant forms of phenylketonuria.
    Danks DM; Cotton RG; Schlesinger P
    Lancet; 1976 Jun; 1(7971):1236-7. PubMed ID: 58275
    [No Abstract]   [Full Text] [Related]  

  • 22. Whole-body autoradiographic studies on the distribution of 14C-labeled D- and L-5-hydroxytryptophan, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid in rats.
    Shindo H; Miyakoshi N
    Chem Pharm Bull (Tokyo); 1976 Dec; 24(12):3158-68. PubMed ID: 1088091
    [No Abstract]   [Full Text] [Related]  

  • 23. The dietary supplement 5-hydroxytryptophan and urinary 5-hydroxyindole acetic acid.
    Preshaw RM; Leavitt D; Hoag G
    CMAJ; 2008 Apr; 178(8):993. PubMed ID: 18390939
    [No Abstract]   [Full Text] [Related]  

  • 24. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
    Partington MW; MacDonald MR
    Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
    [No Abstract]   [Full Text] [Related]  

  • 25. Is monoamine oxydase-B a modifying gene and phenylethylamine a harmful compound in phenylketonuria?
    Ghozlan A; Varoquaux O; Abadie V
    Mol Genet Metab; 2004 Dec; 83(4):337-40. PubMed ID: 15589121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: L-dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine-hydroxylase activity.
    Bartholomé K; Byrd DJ
    Lancet; 1975 Nov; 2(7943):1042-3. PubMed ID: 53531
    [No Abstract]   [Full Text] [Related]  

  • 27. [5-hydroxyindoleacetic acid urinary excretion. I. In the normal child].
    Costil J; Galli J; Richardet JM; Brissaud HE
    Nouv Presse Med; 1973 Sep; 2(32):2115-7. PubMed ID: 4733904
    [No Abstract]   [Full Text] [Related]  

  • 28. Chromatographic determination and mass spectrometric identification of gamma-glutamylphenylalanine, a urinary constituent in phenylketonuria.
    Kamerling JP; Aarsen GJ; Duran M; de Bree PK; van Sprang FJ; Wadman SK
    Clin Chim Acta; 1980 Mar; 102(2-3):137-45. PubMed ID: 7371187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Resorption disorders in children with phenylketonuria].
    Cobet G; Beyreiss K
    Acta Biol Med Ger; 1982; 41(7-8):659-63. PubMed ID: 7148275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Some indices of phenylalanine and tyrosine metabolism in children with phenylketonuria].
    D'iachkova AIa; Lebedev BV
    Vopr Okhr Materin Det; 1969; 14(7):29-32. PubMed ID: 5367726
    [No Abstract]   [Full Text] [Related]  

  • 31. Excretion of pterins in phenylketonuria and phenylketonuria variants.
    Niederwieser A; Curtius HC; Gitzelmann R; Otten A; Baerlocher K; Blehovà B; Berlow S; Gröbe H; Rey F; Schaub J; Scheibenreiter S; Schmidt H; Viscontini M
    Helv Paediatr Acta; 1980 Sep; 35(4):335-42. PubMed ID: 7005193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary excretion of 5-hydroxy-indole-acetic acid in Indian childhood cirrhosis.
    Amla I; Basavraj S; Swamy SK
    Indian Pediatr; 1975 Oct; 12(10):1009-13. PubMed ID: 1228110
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid identification and quantitation of urinary metabolites of phenylalanine in phenylketonuria by gas chromatography.
    Vavich JM; Howell RR
    J Lab Clin Med; 1971 Jan; 77(1):159-67. PubMed ID: 5540425
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correlation between biochemical-biological parameters and intellectual development in treated phenylketonuria children].
    Cobet G; Witkowski R
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():269-75. PubMed ID: 7157122
    [No Abstract]   [Full Text] [Related]  

  • 35. Urinary excretion of 5-hydroxy indole acetic acid (5-HIAA) in children with kwashiorkor.
    Teotia SP; Tripathi TK; Bhaskaran VK; Teotia M; Sharma NL
    Indian Pediatr; 1972 Aug; 9(8):467-70. PubMed ID: 4650710
    [No Abstract]   [Full Text] [Related]  

  • 36. Progress in phenylketonuria: defects in the metabolism of biopterin.
    Berlow S
    Pediatrics; 1980 Apr; 65(4):837-9. PubMed ID: 7367097
    [No Abstract]   [Full Text] [Related]  

  • 37. Maternal phenylketonuria.
    Paprocka J; Jamroz E; Wiktor M; Marszał E
    Wiad Lek; 2009; 62(1):11-7. PubMed ID: 19817251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects.
    Ceci F; Cangiano C; Cairella M; Cascino A; Del Ben M; Muscaritoli M; Sibilia L; Rossi Fanelli F
    J Neural Transm; 1989; 76(2):109-17. PubMed ID: 2468734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The age dependence of 5-hydroxyindoleacetic acid excretion in the urine].
    Emmrich R; Schaaf J
    Z Gesamte Inn Med; 1968 Sep; 23(18):551-3. PubMed ID: 5706732
    [No Abstract]   [Full Text] [Related]  

  • 40. [Excretion of 5-hydroxyindoleacetic acid (5-HIAA) in alcoholic embryopathy].
    Tóth G; Mihai K; Fekete M
    Kinderarztl Prax; 1988 May; 56(5):241-5. PubMed ID: 2463396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.